Unity Software (U) Q4 2024 Earnings Call Transcript
My name is Daniel Meyer, VP and head of investor relations. Our earnings press release and investor spreadsheet is now ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...